BSEAptus Pharma LtdMediumNeutral
Announced Wed, 13 May · 17:39 IST

The Exchange has received the disclosure under Regulation 29(1) / 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Ghanshyam Pansuriya

Promoter Stake BuyPromoter Below 50pctOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-0.4%1-day move
₹185.80
prior close
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.4-1.8-0.4-0.4-2.0-3.4+23.6+14.0+32.9
Up moveDown movePending
AI summary

Promoter Ghanshyam Vinubhai Pansuriya acquired 14,000 equity shares (0.20%) of Aptus Pharma Ltd on 11.05.2026 through unspecified mode. Before the acquisition, he held 3,50,000 shares (5.10% of total equity). After the acquisition, his holding increased to 3,64,000 shares (5.31% of total equity capital of 68,60,000 shares). The acquirer belongs to the Promoter/Promoter Group and the shares are listed on BSE (SME segment, Scrip Code: 544529). This is a relatively small incremental purchase by a promoter at a low base holding.

Likely market impact

A promoter increasing their stake is generally viewed positively as it signals confidence in the company. However, with the acquirer holding only 5.31% of total equity, the ownership change is minor and unlikely to have any immediate material impact on the stock price or company control structure.